Clinical Trial Update: Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating the safety and efficacy of a recombinant and protein-free Factor VIII (rAHF-PFM) in Hemophilia A patients undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant and protein-free Factor VIII (rAHF-PFM) (rAHF-PFM)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 2, Phase 3 | Status: COMPLETED